Combining with other weight loss agents Tesofensine + GLP-1 agonists (theoretical): Different mechanisms = potential synergy Tesofensine: Metabolic + CNS appetite GLP-1s : Strong appetite + gastric slowing Could enhance weight loss to 20-25%+ BUT: No clinical data, significant risks Not recommended without supervision Potential combination benefits: Address multiple pathways Overcome plateaus Better than either alone (theoretically) Metabolic boost + strong appetite suppression Maximum fat loss Combination risks: Compounded cardiovascular strain Unknown drug interactions Excessive weight loss risks Cost ($1,500-2,000/month) Safer alternatives to tesofensine combinations: Tirzepatide alone (15-22% loss, FDA approved) CagriSema (sema + cagrilintide, 15-25%) GLP-1 + lifestyle (safer, proven) Learn about peptide stacking strategies at SeekPeptides
Timelines vary based on the condition being treated
However, sometimes it may indicate an underlying health condition or the beginning of anaphylactic shock
Individuals with uncontrolled diabetes or active cancer should avoid both peptides without guidance from a healthcare professional
(PubMed) Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH
On a U-100 insulin syringe, 1mL = 100 units
